Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1996 7
1997 10
1998 6
1999 11
2000 5
2001 7
2002 13
2003 18
2004 14
2005 29
2006 28
2007 31
2008 28
2009 22
2010 18
2011 14
2012 10
2013 16
2014 28
2015 17
2016 16
2017 24
2018 24
2019 13
2020 19
2021 27
2022 15
2023 9
2024 22
2025 16
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

494 results

Results by year

Filters applied: . Clear all
Page 1
Amylin: Pharmacology, Physiology, and Clinical Potential.
Hay DL, Chen S, Lutz TA, Parkes DG, Roth JD. Hay DL, et al. Pharmacol Rev. 2015 Jul;67(3):564-600. doi: 10.1124/pr.115.010629. Pharmacol Rev. 2015. PMID: 26071095 Free article. Review.
Amylin acts principally in the circumventricular organs of the central nervous system and functionally interacts with other metabolically active hormones such as cholecystokinin, leptin, and estradiol. The amylin-based peptide, pramlintide, is used clinically to treat type …
Amylin acts principally in the circumventricular organs of the central nervous system and functionally interacts with other metabolically ac …
Pramlintide.
[No authors listed] [No authors listed] 2016 Jun 6. LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2016 Jun 6. LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644254 Free Books & Documents. Review.
Pramlintide is a recombinant DNA produced polypeptide analogue of human amylin that is used in combination with insulin in the therapy of diabetes. Pramlintide has not been associated with serum enzyme elevations during therapy or with instances of clinically appare …
Pramlintide is a recombinant DNA produced polypeptide analogue of human amylin that is used in combination with insulin in the therap …
Pramlintide.
[No authors listed] [No authors listed] 2026 May 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2026 May 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000033 Free Books & Documents. Review.
Pramlintide has a high molecular weight, so it is unlikely to pass into breastmilk in clinically important amounts. ...If there is concern, monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with pramlintide.[1]...
Pramlintide has a high molecular weight, so it is unlikely to pass into breastmilk in clinically important amounts. ...If there is co …
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance.
Apostolopoulou M, Lambadiari V, Roden M, Dimitriadis GD. Apostolopoulou M, et al. Endocr Rev. 2025 May 9;46(3):317-348. doi: 10.1210/endrev/bnae032. Endocr Rev. 2025. PMID: 39998445 Free PMC article. Review.
Among other concepts, metformin, pioglitazone, incretin-based drugs such as GLP-1 receptor agonists, sodium-glucose cotransporter inhibitors, and pramlintide can improve insulin resistance, either directly or indirectly. However, considering the current issues of high cost …
Among other concepts, metformin, pioglitazone, incretin-based drugs such as GLP-1 receptor agonists, sodium-glucose cotransporter inhibitors …
Pramlintide acetate.
McQueen J. McQueen J. Am J Health Syst Pharm. 2005 Nov 15;62(22):2363-72. doi: 10.2146/ajhp050341. Am J Health Syst Pharm. 2005. PMID: 16278328 Review.
PURPOSE: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of pramlintide are reviewed. SUMMARY: Pramlintide, a synthetic analogue of the human hormone amylin, is the first of a new class of amylinomimetic compound …
PURPOSE: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of pramlintide are rev …
Development of Cagrilintide, a Long-Acting Amylin Analogue.
Kruse T, Hansen JL, Dahl K, Schäffer L, Sensfuss U, Poulsen C, Schlein M, Hansen AMK, Jeppesen CB, Dornonville de la Cour C, Clausen TR, Johansson E, Fulle S, Skyggebjerg RB, Raun K. Kruse T, et al. J Med Chem. 2021 Aug 12;64(15):11183-11194. doi: 10.1021/acs.jmedchem.1c00565. Epub 2021 Jul 21. J Med Chem. 2021. PMID: 34288673 Free article.
A hallmark of the pancreatic hormone amylin is its high propensity toward the formation of amyloid fibrils, which makes it a challenging drug design effort. The amylin analogue pramlintide is commercially available for diabetes treatment as an adjunct to insulin therapy bu …
A hallmark of the pancreatic hormone amylin is its high propensity toward the formation of amyloid fibrils, which makes it a challenging dru …
Pramlintide: (AC 137, AC 0137, Symlin, Tripro-Amylin).
[No authors listed] [No authors listed] BioDrugs. 2003;17(1):73-9. doi: 10.2165/00063030-200317010-00008. BioDrugs. 2003. PMID: 12534323 Review.
Development - US: Amylin has submitted an NDA in the US for pramlintide acetate (Symlin trade mark ) as an adjunctive therapy for the treatment of type 1 and type 2 diabetes mellitus. ...Amylin completed pivotal phase III clinical trials with pramlintide acet …
Development - US: Amylin has submitted an NDA in the US for pramlintide acetate (Symlin trade mark ) as an adjunctive therapy …
Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity.
Eržen S, Tonin G, Jurišić Eržen D, Klen J. Eržen S, et al. Int J Mol Sci. 2024 Jan 26;25(3):1517. doi: 10.3390/ijms25031517. Int J Mol Sci. 2024. PMID: 38338796 Free PMC article. Review.
In this narrative review, we summarized the current evidence and ongoing studies on the mechanism of action, clinical pharmacology, and applications of amylin and its analogs, pramlintide and cagrilintide, in the field of diabetology, endocrinology, and metabolism disorder …
In this narrative review, we summarized the current evidence and ongoing studies on the mechanism of action, clinical pharmacology, and appl …
Pramlintide (symlin) for diabetes.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2005 May 23;47(1209):43-4. Med Lett Drugs Ther. 2005. PMID: 15912124
Amylin analogs for the treatment of obesity without diabetes: present and future.
Panou T, Gouveri E, Popovic DS, Papanas N. Panou T, et al. Expert Rev Clin Pharmacol. 2024 Sep 30:1-9. doi: 10.1080/17512433.2024.2409403. Online ahead of print. Expert Rev Clin Pharmacol. 2024. PMID: 39317404 Review.
Amylin is a major regulatory hormone for satiation and food intake perception in humans. Amylin analogs (pramlintide and cagrilintide) are emerging as promising anti-obesity agents in non-DM subjects. AREAS COVERED: Pramlintide, the first amylin analog, initially us …
Amylin is a major regulatory hormone for satiation and food intake perception in humans. Amylin analogs (pramlintide and cagrilintide …
494 results